Status:
TERMINATED
Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
Lead Sponsor:
The Cooper Health System
Conditions:
Depression, Postpartum
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this project is to assess the effectiveness of preventative antidepressants immediately following delivery on postpartum depression rates in women at high risk due to prior history of d...
Detailed Description
Eligible women for our study would be identified antepartum from our three obstetrical groups delivering at Cooper University Hospital: Cooper Faculty Group, Women's Care Center, and CamCare. Potentia...
Eligibility Criteria
Inclusion
- Past history of depression or postpartum depression
- Singleton gestation
- Delivery \> 34 weeks gestation
- No current clinical evidence of depression
- Able to read and understand written English language
Exclusion
- Multiple gestation
- Delivery prior to 34 weeks
- Delivery outside of Cooper University Hospital
- Major fetal anomaly or fetal demise
- Current use of antidepressants
- Evidence of active depression at antepartum evaluation
- Edinburgh Postpartum Depression scale of \>12 prior to discharge from the hospital
- Maternal age \< 18 years
- Infant in Neonatal Intensive Care Unit (NICU) at time of patient discharge from hospital
- Known or suspected allergy to Sertraline
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT02235064
Start Date
July 1 2014
End Date
July 1 2015
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103